Your browser doesn't support javascript.
loading
Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.
Lott, Aline M; Danner, Anissa N; Malte, Carol A; Williams, Emily C; Gordon, Adam J; Halvorson, Max A; Saxon, Andrew J; Hagedorn, Hildi J; Sayre, George G; Hawkins, Eric J.
Afiliação
  • Lott AM; From the Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA (AML, AND, CAM, AJS, EJH); Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research and Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA (AML, AND, CAM, ECW, AJS, GGS, EJH); Department of Health Systems and Population Health, University of Washington, Seattle, WA (ECW); Informatics, Decision-Enhancement
J Addict Med ; 17(4): e262-e268, 2023.
Article em En | MEDLINE | ID: mdl-37579107

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Telemedicina / COVID-19 / Transtornos Relacionados ao Uso de Opioides Limite: Humans Idioma: En Ano de publicação: 2023

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Telemedicina / COVID-19 / Transtornos Relacionados ao Uso de Opioides Limite: Humans Idioma: En Ano de publicação: 2023